The aim was to evaluate the efficacy and safety of volatile anaesthetic for postoperative sedation in adult cardiac surgery patients through a systematic review and meta-analysis. We retrieved randomized controlled trials from MEDLINE, EMBASE, CENTRAL, Web of Science, clinical trials registries, conference proceedings, and reference lists of included articles. Independent reviewers extracted data, including patient characteristics, type of intraoperative anaesthesia, inhaled anaesthetic used, comparator sedation, and outcomes of interest, using pre-piloted forms. We assessed risk of bias using the Cochrane Tool and evaluated the strength of the evidence using the GRADE approach. Eight studies enrolling 610 patients were included. Seven had a high and one a low risk of bias. The times to extubation after intensive care unit (ICU) admission and sedation discontinuation were, respectively, 76 [95% confidence interval (CI) À150 to À 2, I
Early extubation is a key component of 'fast-track' care after cardiac surgery and is associated with shorter intensive care unit (ICU) length of stay (LOS), 1 2 reduced costs, and improved efficiency. 1 2 I.V. sedative and analgesic medications are administered to facilitate tolerance of mechanical ventilation and alleviate postoperative pain and anxiety. However, these agents have shortcomings in the setting of a 'fast-track' approach, including prolonged mechanical ventilation, over-sedation, delirium, and haemodynamic instability. 3 4 Volatile anaesthetics have an excellent safety record, and their pharmacokinetic and pharmacodynamic properties are ideally suited to the setting of the cardiac surgical ICU. They provide amnesia, and their low solubility in the blood allows for effective sedation and rapid recovery after discontinuation. 5 In addition, their elimination is independent of renal and hepatic function, which are often impaired in cardiac surgical patients, 5 and some evidence suggests possible cardioprotective properties. 6 7 Since the development of the Anaesthetic Conserving Device (AnaConDa TM ; Sedana Medical, Uppsala, Sweden), 8 which allows for volatile anaesthetic administration through common ICU ventilators, their use in this setting has increased. Randomized controlled trials (RCTs) have demonstrated shorter time to extubation with volatile anaesthetic when compared with i.v. sedation, [9] [10] [11] [12] [13] and studies specific to the cardiac surgery population have found less myocardial damage. 14 15 Evidence regarding the use of these agents is derived from small, single-centre studies that are underpowered to show an impact on ICU or hospital LOS, major adverse cardiovascular events, or mortality. To our knowledge, no systematic review on the effects of volatile anaesthetic usage for sedation exclusively in the cardiac surgical ICU setting has been published, although two reviews combining medical, surgical, and cardiac surgical ICU patients have been completed. 16 17 Given that cardiac surgery patients are a unique population with both underlying physiology and administrative considerations that are distinct from medical and surgical ICU patients, we undertook a systematic review and meta-analysis comparing volatile anaesthetic sedation with standard care in postoperative cardiac surgical patients, emphasizing their use in the context of a fast-track approach to cardiac surgical care.
Methods
We registered a protocol 18 developed a priori that adhered to the Methodological Expectations of Cochrane Intervention Reviews. 19 This protocol provided the framework for our review, which is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 20 Our review addresses the question: 'What is the efficacy and safety of inhaled anaesthetic for postoperative sedation during mechanical ventilation compared with i.v. sedation in adult patients who have undergone cardiac surgery?'
Criteria for study inclusion
We included RCTs comparing postoperative sedation with inhaled anaesthetic (desflurane, sevoflurane, isoflurane, enflurane, or xenon) with i.v. sedation in adult patients undergoing cardiac surgery. Sedation modality could be initiated in the operating room (OR) or ICU but needed to be continued for at least 2 h after surgery from the time of ICU admission. We used this cut-off based on the assumption that application of inhaled anaesthetic sedation for a shorter period would not allow adequate exposure to the intervention to assess its effects adequately and that requiring a longer duration would not be consistent with a 'fast-track' approach. Crossover studies were excluded. Our outcomes were time to extubation, ICU and hospital LOS, postoperative troponin elevation during the first 24 h after surgery, myocardial and cerebrovascular morbidity and mortality during the first 30 postoperative days (as defined in the trials), acute kidney injury (AKI), proportion of time within target range on a recognized sedation scale, inpatient costs, and the incidence of environmental pollution. 21 22 Search method for identification of studies 
Data collection and analysis
Selection of studies All references were screened by evaluation of title and abstract by two independent reviewers. If a reference was deemed potentially eligible by at least one reviewer, its full text report was retrieved. Two reviewers then independently assessed study eligibility using pre-piloted forms. We included studies that fulfilled all eligibility criteria. Agreement at each step was assessed using j statistics.
Data extraction and management
Independent reviewers extracted data using pre-piloted forms. Data extracted included first author, title, year and type of publication, patient demographics, type of intraoperative anaesthesia, inhaled anaesthetic used for postoperative sedation, comparator sedation, and the outcomes of interest. Information pertaining to methodological quality was also collected.
Editor's key points
• Volatile anaesthetics present the potential for an attractive risk-benefit profile in postsurgical sedation on the cardiac intensive care unit.
• In this meta-analysis, the authors reviewed the findings of eight clinical studies, comprising 610 subjects.
• They concluded that the available evidence indicates a shorter time to extubation after sedation using volatile agents, and a slightly lower troponin concetration, but no discernible difference in length of stay in the intensive care unit or the hospital.
We performed statistical analyses using RevMan 5.3 statistical software 23 for meta-analysis. Data were then imported into GRADEpro software 24 for preparation of the evidence profile.
Assessment of risk of bias
Two reviewers independently assessed risk of bias for each included study using the Cochrane Collaboration tool. 25 Studies were classified as overall 'high risk of bias' if graded as having a high risk of bias in a single domain or unclear risk of bias in two or more domains. Overall agreement was evaluated using weighted j statistics. At all stages, conflicts between reviewers were resolved through discussion.
Measures of treatment effect
Results are presented as the mean difference (MD) with 95% confidence intervals (Cis). Many studies reported outcomes as the median and interquartile range (IQR) because of their nonnormal distribution. To calculate a pooled effect estimate, these were converted to means and SDs using validated methods. 26 27 In one study, 28 two groups met the control group criteria. Their means and SDs were combined using a method previously described.
26
Dealing with missing data Authors were contacted in an attempt to obtain relevant, unreported data. Two attempts were made, after which we considered data missing.
Assessment of heterogeneity
We assessed for heterogeneity between studies using the I 2 statistic (I 2 >50% considered significant). Heterogeneity was investigated by verifying data accuracy and undertaking subgroup analyses if there was at least one study per subgroup. In doing so, we used an interaction test, with P<0.05 considered significant. Subgroup analyses were conducted even in the absence of statistical heterogeneity, because subgroup effects may be present even in the presence of homogeneous heterogeneity test results.
29
A priori hypotheses to explain heterogeneity Potential and expected clinical sources of heterogeneity included differences in intraoperative anaesthetic technique and anaesthetic gas used, differences in baseline patient characteristics, and differences in adjunct and comparison i.v. agents. To explore any identified heterogeneity, we conducted, when possible, the following subgroup analyses. (i) Patients sedated using sevoflurane or desflurane as opposed to enflurane or isoflurane, hypothesizing that time to extubation (and, as a result, LOS) would be significantly longer in the latter group given the significantly lower blood:gas solubility and associated offset time of sevoflurane and desflurane. (ii) Patients in studies where the control group was sedated using a benzodiazepine or opioid as opposed to propofol, hypothesizing that there would be a greater reduction in time to extubation given the short context-sensitive half-time of propofol when compared with these other two classes of medication. (iii) Studies involving intraoperative total i.v. anaesthesia (TIVA) compared to studies using intraoperative inhaled anaesthetic and i.v. agents, hypothesizing that there would be a greater reduction in time to extubation in studies using intraoperative inhaled anaesthetic and i.v. agents. (iv) We had a priori intended to evaluate studies with high risk of bias (using the criteria defined above); however, this was not done, because all studies except one (Soro and colleagues) 30 had a high risk of bias, and the primary outcomes reported by Soro and colleagues 30 were not heterogeneous (ICU LOS and hospital LOS). We did include this subgroup analysis in our examination of postoperative troponin concentration.
(v) We also undertook a post hoc subgroup analysis evaluating the effect of use of cardiopulmoary bypass (CPB) compared with off-pump surgery, specifically as applied to postoperative troponin concentration.
Assessment of reporting biases
Eight studies met eligibility criteria. We did not use a funnel plot or the Egger test to assess for publication bias, because these are not reliable when applied to <10 studies. 26 
Summarization of results
When appropriate, outcome data were pooled. 23 Effect sizes were estimated for each outcome and study weights measured using the inverse variance method. Weighted effect sizes were calculated using a random-effects model (DerSimonian-Laird method). 27 We did so because we anticipated that there would be substantial unexplained heterogeneity in our results, given the multiple factors that can influence our outcomes of interest, beyond type of sedation. A random-effects meta-analysis model assumes that the estimates of effect being studied in different trials are not identical but are drawn from a normal distribution. 27 Two of our a priori outcomes (cardiovascular morbidity and mortality and effectiveness of sedation) were measured using varied definitions and described narratively.
Assessment of confidence in estimates of effect
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the quality of the evidence for each outcome 31 (see Supplementary Appendix 3).
Results

Literature search
The electronic search retrieved 1681 non-duplicate studies, 1641 of which were excluded through abstract and title screening. Twelve conference abstracts and 28 full-text articles were reviewed. Each conference abstract was found either not to meet inclusion criteria or to represent duplicate data to those published in one of our included RCTs. One ongoing study was identified in the clinicaltrials.gov database, 32 but results were not yet available. In total, eight studies were included (weighted j¼1.0; see Fig. 1 ). Missing data were obtained from the author of one included RCT. 14 
Included studies
A total of eight RCTs (n¼610) were included (see Table 1 ). Participants were primarily undergoing first-time, elective coronary artery bypass graft (CABG) surgery on CPB. One study included patients undergoing elective first-time off-pump CABG, 28 and two studies included a mix of surgical subtypes. 14, 33 All studies included only patients at low to moderate risk of adverse perioperative outcomes, and all except one 34 enrolled both sexes. One study evaluated the use of isoflurane; 33 the remainder evaluated sevoflurane. All studies compared volatile anaesthetic with propofol i.v. except for one, which compared it with i.v. midazolam. 34 
Risk of bias
The risk of bias for included studies is summarized in Fig. 2 . Given that only Soro and colleagues 30 used blinding, the risk of bias was high in all other studies. In addition, most studies either explicitly used a per protocol analysis, resulting in a high risk of attrition bias, or did not provide enough information to establish clearly that an intention-to-treat analysis was used, resulting in an unclear risk of bias.
Outcomes
Time to extubation Six studies 9 13 14 33-36 evaluated the effect of volatile sedation on time to extubation; one reported only time from ICU admission until extubation, 9 whereas another reported only time to extubation after discontinuation of sedation. 34 The times to extubation after ICU admission and sedation discontinuation were, respectively, 76 (95% CI À150 to À2, I 2 ¼79%) and 74 min (95% CI À126 to À23, I 2 ¼96%) less in patients who were sedated using volatile anaesthetic (see Figs 3 and 4) . The significant heterogeneity was explored using several prespecified subgroup analyses (Supplementary Appendix 4) ; substantial heterogeneity remained unaccounted for. The overall quality of the evidence for time to extubation from ICU admission was very low, related to lack of blinding, small study size, and heterogeneity not explained by subgroup analyses. Owing to the large relative effect (a 62% decrease in time to extubation), the quality of evidence was upgraded to moderate for time to extubation from discontinuation of sedation. Wrong intervention (7) Wrong population (4) Wrong outcomes (3) Not an RCT (9) 
ICU LOS (in hours)
Reported in six studies including 509 patients, We undertook subgroup analyses to examine whether a longacting comparator or intraoperative anaesthetic agent was an effect modifier. Neither was found to have a significant interaction effect (Supplementary Appendix 5) . The overall quality of evidence for no effect on ICU LOS was high.
Hospital LOS Six studies reported hospital LOS (Fig. 6 troponin concentrations at 2, 4, and 12 h after surgery 37 was not included, because troponin concentration after cardiac surgery has been shown to peak at 18 h. 38 Patients who received volatile anaesthetic sedation had troponin concentrations that were 0.71 ng ml À1 (95% CI 0.23-1.2) lower than control patients (Fig. 7) .
We undertook three subgroup analyses (Supplementary Appendix 7) evaluating intraoperative anaesthetic agent, risk of bias, and use of CPB (established post hoc). Interaction was significant only for use of CPB (v 2 ¼7.93; P¼0.005). The overall quality of evidence was graded as high.
Composite outcome of cardiovascular morbidity and mortality Five studies reported this outcome, 9 33 30 35 but definitions varied, and we chose not to pool the data (Table 2) . No study reported a between-group difference in adverse cardiovascular outcomes.
Postoperative AKI Only one study 36 reported AKI in 1/35 treatment and 1/35 control patients. 
Effectiveness of sedation
Four studies 9 13 33 34 included measures of the effectiveness of sedation. These measures, which included the proportion of time in the target sedation scale range, average sedation scale score, incidence of agitation, and number of bolus doses and dose changes required, were deemed unsuitable for metaanalysis and instead described narratively (Table 3) . One study reported a statistically significant decrease in the number of dose changes in the volatile anaesthetic group. 33 Otherwise, there was no difference in any of the measures of effectiveness of sedation.
Difference in inpatient costs
Only one study 30 Incidence of environmental pollution None of the included studies evaluated ambient pollution by volatile agents.
Discussion
Summary of main results
In this systematic review of eight small studies, volatile anaesthetic sedation after cardiac surgery was associated with earlier extubation. From ICU admission, the time to extubation was decreased by 16% (76 min), and from discontinuation of sedation, the time to extubation was decreased by 62% (74 min). These results are similar in direction and magnitude of effect to those reported in previous systematic reviews of volatile sedation in the combined medical, surgical, and cardiac surgical ICU population. 16 17 Although statistically significant, these results demonstrated heterogeneity that was only partly accounted for by subgroup analyses (see Supplementary Appendix 8 for a summary of all subgroup analyses). Clinically, the time from discontinuation of sedation is a more useful measure, because the events that influence when sedation is turned off are likely not to be related to sedation modality, whereas the time to extubation from discontinuation of sedation is more likely to be related to the pharmacokinetic and pharmacodynamic properties of the agent administered.
Despite its effect on time to extubation, volatile sedation had no effect on ICU or hospital LOS. Although these outcomes have inherent noise related to health-care system structure, this finding demonstrated no heterogeneity. The lack of effect on ICU LOS could potentially be attributable to other factors influencing patient transfer out of the ICU, such as the availability of ward beds and the demand for critical care beds. A single study 36 demonstrated a reduction in hospital LOS with volatile sedation, but its small magnitude and lack of precision meant that it had no significant influence on heterogeneity or the pooled estimate of effect. 28 Not reported n/a n/a n/a n/a n/a
Hanafy (2005) 34 Not reported n/a n/a n/a n/a n/a
Hellström and colle agues (2011, 2012) 13 35 Incidence of one or more of: (i) 14 Not reported n/a n/a n/a n/a n/a 28 Not measured n/a n/a n/a n/a n/a
Hanafy (2005) 34 Number of bolus doses of sedation agent and incidence of agitation (defined as RSS¼1) 36 Not measured n/a n/a n/a n/a n/a Soro and colleagues (2012) 30 Not measured n/a n/a n/a n/a n/a
Steurer and colleagues (2012) 14 Not measured n/a n/a n/a n/a n/a Three studies, including 215 patients, 14 28 30 measured postoperative troponin and found a significant reduction at 24 h. Given that a troponin elevation greater than 10 times the upper limit of normal (which in most laboratories is 0.04 ng ml
À1
) is the biomarker criterion for MI, 27 a reduction of 0.71 ng ml À1 may represent clinically significant myocardial damage because it exceeds the threshold of 0.4 ng ml À1 defined in the Third Universal Definition of Myocardial Infarction. 27 This is in spite of the fact that all three studies compared volatile sedation with propofol, which itself may have cardioprotective properties. 35 36 However, other trials looking at other biomarkers 36 and time points 37 have found no difference in biomarker level with the use of volatile sedation. Owing to the variable reporting of morbidity and mortality, the potential cardioprotective effect of volatile anaesthetic sedation and its clinical implications requires further investigation. Although none of the included trials measured the effect of volatile sedation on environmental and ambient pollution, several technical reports in similar settings suggest it is not a significant concern. 22 39 Sedation effectiveness data suggest that volatiles were similar to i.v. sedation, albeit based on narrative evidence unsuitable for calculation of a pooled effect.
Overall completeness and applicability of evidence
All included studies examined low-to moderate-risk patients, the population that is typically selected for fast-track approaches, ensuring external validity. The overall effect on time to extubation after sedation discontinuation was substantial, resulting in a pooled treatment effect that is likely to be real and, because of its similarity to extubation time after ICU admission, possibly related to pharmacological differences. The lack of effect on ICU and hospital LOS also appears real, although, given the small sample size, this must be interpreted with caution. Results may not, however, apply to high-risk patients. The major gap in the literature relates to patient-important outcomes. Even though volatile sedation appears to reduce myocardial injury, there is a need for large trials to establish clearly the impact on morbidity and mortality. In addition, only one study reported the incidence of postoperative AKI, a theoretical adverse effect of prolonged volatile anaesthetic sedation.
Finally, all except one included trial had a high risk of bias, because of either per protocol analysis or lack of blinding. Blinding was implemented successfully by Soro and coworkers, 30 who vaporized saline via the AnaConDa device as a placebo for patients in the control arm and infused Intralipid (a form of parenteral nutrition) to mimic the infusion of propofol. This has limitations, in that Intralipid may be perceived as an intervention and has been speculated to have an antioxidant effect. 9 More suitable blinding for i.v. sedation infusion could use opaque tubing and syringes, through which saline (a more appropriate placebo agent) could be infused.
Potential biases in the review process
A limitation of this review is that only one included trial had a low risk of bias in all domains. The remainder had at least two domains with high risk of bias, in addition to two or more domains with unclear risk of bias. The lack of blinding in all trials may affect the magnitude of effect on time to extubation. Unfortunately, we were unable to undertake subgroup analyses evaluating the impact of blinding on estimates of effect.
In addition, we cannot rule out the presence of publication bias because we could not use funnel plots or the Egger test. However, we completed an extensive grey literature review and did not discover unpublished data.
Finally, because of the non-normal distribution of three of our outcomes, they often had to be converted for pooling. In addition, biomarker data published in one study were only presented graphically, 30 and thus digitally extracted. Owing to the potential for error in each arithmetic step and the assumptions required to convert medians to means, these may not accurately represent the outcomes that they are derived from.
Conclusions
Low-to moderate-risk adult patients may benefit from volatile sedation after undergoing uncomplicated cardiac surgery. Data suggest that the benefits include a reduction in time to extubation and troponin concentration at 24 h. There is inadequate information to evaluate whether or not it has an impact on morbidity, mortality, or other patient-important outcomes. Large trials that use an intention-to-treat analysis are required before further judgements can be made.
